Coya Therapeutics, Inc. (COYA) (CIK 0001835022) CORRESP

Coya Therapeutics, Inc. (COYA) (CIK 0001835022) → SEC staff · filed 2026-03-19 · ticker COYA · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001193125-26-115931
Form
CORRESP
Filer
Coya Therapeutics, Inc. (COYA) (CIK 0001835022)
CIK
0001835022
Ticker
COYA
Filed
2026-03-19
SIC industry
2834
HQ
Houston, TX

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1835022/000119312526115931/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗

Other comment-letter activity for this filer